Yazıcı A - Search Results

1

The Effect of Low-Dose Aspirin on Dry Eye Parameters and Ocular Surface Disease Index Questionnaire.

Yazıcı A, Sarı E, Ayhan E, Şahin G, Tıskaoğlu NS, Gürbüzer T, Kurt H, Ermiş SS. Yazıcı A, et al. J Ocul Pharmacol Ther. 2018 Apr;34(3):256-259. doi: 10.1089/jop.2017.0064. Epub 2018 Feb 1. J Ocul Pharmacol Ther. 2018. PMID: 29388864

2

Dry Eye Disease in Patients with Newly Diagnosed Depressive Disorder.

Tiskaoglu NS, Yazıcı A, Karlıdere T, Sari E, Oguz EY, Musaoglu M, Aslan S, Samet Ermiş S. Tiskaoglu NS, et al. Among authors: yazici a. Curr Eye Res. 2017 May;42(5):672-676. doi: 10.1080/02713683.2016.1236966. Epub 2016 Nov 21. Curr Eye Res. 2017. PMID: 27870590

3

Change in tear film characteristics in visual display terminal users.

Yazici A, Sari ES, Sahin G, Kilic A, Cakmak H, Ayar O, Ermis SS. Yazici A, et al. Eur J Ophthalmol. 2015 Mar-Apr;25(2):85-9. doi: 10.5301/ejo.5000525. Epub 2014 Oct 8. Eur J Ophthalmol. 2015. PMID: 25363850

4

Alterations of Choroidal Thickness With Diabetic Neuropathy.

Yazici A, Sogutlu Sari E, Koc R, Sahin G, Kurt H, Ozdal PC, Ermis SS. Yazici A, et al. Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1518-22. doi: 10.1167/iovs.15-17966. Invest Ophthalmol Vis Sci. 2016. PMID: 27035624

5

The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.

Sogutlu Sari E, Yazici A, Eser B, Erol MK, Kilic A, Ermis SS, Koytak A, Akşit H, Yakut T. Sogutlu Sari E, et al. Among authors: yazici a. Cutan Ocul Toxicol. 2014 Dec;33(4):270-4. doi: 10.3109/15569527.2013.854372. Epub 2014 Jan 22. Cutan Ocul Toxicol. 2014. PMID: 24446892

6

The protective effect of selenium in cisplatin-related retinotoxicity.

Yazici A, Sogutlu-Sari E, Yay A, Aksit H, Kilic A, Aksit D, Yildiz O, Ermis SS. Yazici A, et al. Cutan Ocul Toxicol. 2014 Dec;33(4):327-32. doi: 10.3109/15569527.2013.879877. Epub 2014 Mar 18. Cutan Ocul Toxicol. 2014. PMID: 24641118

7

Lacrimal Gland Volume Changes in Unilateral Primary Acquired Nasolacrimal Obstruction.

Yazici A, Bulbul E, Yazici H, Sari E, Tiskaoglu N, Yanik B, Ermis S. Yazici A, et al. Among authors: yazici h. Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4425-9. doi: 10.1167/iovs.15-16873. Invest Ophthalmol Vis Sci. 2015. PMID: 26193918

8

Reduced tear break-up time in the fellow eye of patients with unilateral primary acquired nasolacrimal duct obstruction.

Tıskaoğlu NS, Yazıcı A. Tıskaoğlu NS, et al. Among authors: yazici a. Int Ophthalmol. 2023 Mar;43(3):965-971. doi: 10.1007/s10792-022-02498-w. Epub 2022 Sep 2. Int Ophthalmol. 2023. PMID: 36053478

9

Tear instability in the fellow eye of unilateral nasolacrimal obstruction and resolution with dacryocystorhinostomy.

Tıskaoğlu NS, Yazıcı A. Tıskaoğlu NS, et al. Among authors: yazici a. Orbit. 2023 Aug;42(4):404-410. doi: 10.1080/01676830.2022.2119261. Epub 2022 Sep 7. Orbit. 2023. PMID: 36069079

10

The effect of intracameral anesthesia on macular thickness and ganglion cell-inner plexiform layer thickness after uneventful phacoemulsification surgery: prospective and randomized controlled trial.

Sari ES, Ermis SS, Yazici A, Koytak A, Sahin G, Kilic A. Sari ES, et al. Among authors: yazici a. Graefes Arch Clin Exp Ophthalmol. 2014 Mar;252(3):433-9. doi: 10.1007/s00417-013-2557-3. Epub 2014 Jan 5. Graefes Arch Clin Exp Ophthalmol. 2014. PMID: 24390400 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

484 results

Search Page